Inozyme Pharma, Inc. Quarterly Interest Expense in USD from Q1 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Inozyme Pharma, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2023 to Q2 2024.
  • Inozyme Pharma, Inc. Interest Expense for the quarter ending June 30, 2024 was $1.4M, a 80.9% increase year-over-year.
  • Inozyme Pharma, Inc. annual Interest Expense for 2023 was $3.33M, a 1172% increase from 2022.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.4M +$624K +80.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.33M +$997K +304% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q2 2023 $771K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $328K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.